Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism Nitric oxide stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaNO |
InChIKeyMWUXSHHQAYIFBG-UHFFFAOYSA-N |
CAS Registry10102-43-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Tuberculosis | Phase 2 | ZA | 27 Sep 2023 | |
COVID-19 respiratory infection | Phase 2 | GB | 01 Sep 2021 | |
Post Acute COVID 19 Syndrome | Phase 2 | GB | 01 Sep 2021 | |
Viral respiratory infection | Phase 2 | GB | 01 Sep 2021 | |
COVID-19 | Phase 1 | GB | 01 Apr 2021 | |
Bronchiectasis | Discovery | GB | 01 Apr 2021 | |
Pulmonary Disease, Chronic Obstructive | Discovery | GB | 01 Apr 2021 |